Abstract
Generic (i.e. non-branded medicine) and therapeutic (i.e. a less expensive drug from the same class) substitution of medication provides considerable financial savings, but may negatively impact on patients. We report secondary qualitative/quantitative analysis of stroke survivors from a pilot randomised controlled brief intervention to increase adherence to medication. Patients’ experiences of medication changes were examined in conjunction with electronically-recorded medication adherence. Twenty-eight patients reported frequent medication changes (e.g. size/shape/colour/packaging) and two-thirds of these reported negative effects, resulting in, at least, confusion and, at worst, mistakes in medication-taking. Patients reporting a direct effect on their medication-taking (n = 6) demonstrated poorer objectively-measured adherence (i.e. % doses taken on schedule) than those reporting confusion [mean difference = 19.9, 95 % CI (2.0, 37.8)] or no problems [mean difference = 20.6, 95 % CI (1.6, 40.0)]. Changes to medication resulting from switching between generic brands can be associated with notable problems, including poorer medication adherence, for a significant minority.
Original language | English |
---|---|
Pages (from-to) | 890-901 |
Number of pages | 12 |
Journal | Journal of Behavioral Medicine |
Volume | 37 |
Issue number | 5 |
Early online date | 14 Dec 2013 |
DOIs | |
Publication status | Published - Oct 2014 |
Bibliographical note
This project was funded by a grant from the Scottish Government, Department of Health, Chief Scientist Office; reference number CZH/4/569. We would like to thank the doctors and nurses at the Western General Hospital stroke clinic and ward for their help in recruitment, and the patients for giving up their time to take part.Keywords
- stroke
- adherence
- medication
- generic substitution
- therapeutic substitution